Patents
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
08/2004
08/12/2004US20040157818 antagonism to chemokine receptor CXCR4 for treatment of rheumatism or cancer metastasis
08/12/2004DE10304294A1 N-Substituierte(Benzoimidazol-2-yl)-phenyl, Verfahren zu ihrer Herstellung , ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament N-substituted (benzoimidazol-2-yl) -phenyl, processes for their preparation, their use as a medicament or diagnostic, and medicament containing them
08/12/2004DE10303581A1 Acetoacetylierung von Alkoholen, Thiolen und Aminen im Mikroreaktor Acetoacetylation of alcohols, thiols and amines in the microreactor
08/12/2004CA2514656A1 5ht7 antagonists and inverse agonists
08/11/2004EP1445250A1 Novel amine derivative having human beta-tryptase inhibitory activity and drugs containing the same
08/11/2004EP1142860B1 Intermediates and process for producing fluorine-containing amino acid compound by using the same
08/11/2004CN1519234A Preparation of hydrochloric albendazole sulfoxide
08/11/2004CN1161340C Benzimidazole compounds that are vitronectin receptor antagoninsts
08/10/2004US6774242 Method for arylating aza-heterocycles with activated aromatic compounds in the presence of caesium carbonate
08/10/2004US6774239 Process for the preparation of N,N′-carbonyldiazoles and azolide salts
08/10/2004US6774134 For therapy of respiratory syncytial virus infection
08/10/2004CA2148613C 2-perhalogenalkyl-substituted benzimidazoles, their preparation and their use as pesticides
08/05/2004WO2004065383A2 Novel synthesis of irbesartan
08/05/2004WO2004065370A1 Glycogen synthase kinase 3beta inhibitor, composition and process for the preparation thereof
08/05/2004WO2004064835A1 Use of ion channel modulating agents for treating pain
08/05/2004WO2004064723A2 Inhibitors and methods of use thereof
08/05/2004WO2004032861A3 Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents
08/05/2004WO2003059289A3 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
08/05/2004US20040152890 Substituted heterocyclic compounds
08/05/2004US20040152743 Heterocyclically substituted benzoylureas, process for their preparation and their use as pharmaceuticals
08/05/2004US20040152707 Analgesics; anxiolytic agents; antihistamines; antitussive agents; antidepressants; alcoholism
08/05/2004US20040152690 Analgesics; neuropathic pain; antiinflamamtory agents; oral diseases; headaches; antiarthritic agents; vision disorders; skin disorders; inflammatory bowel disorders; benzimidazole compounds
08/05/2004US20040152670 For therapy of diseases of central nervous system related to the metabotropic glutamate receptor system
08/05/2004US20040152669 Anti-bacterial agents based upon oxoanion binding
08/05/2004US20040151945 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes
08/05/2004US20040151773 core containing a complex of the benzimidazole derivative e.g., omeprazole, lansoprazole, pantoprazole, or timoprazole, and ion-exchange resin, and the enteric coating agent having the degree of substitution by an acidic group of less than 30%,
08/05/2004DE10304374A1 Neue substituierte 2-Aminoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament New substituted 2-Aminoimidazole, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing
08/05/2004CA2513373A1 Novel synthesis of irbesartan
08/05/2004CA2485565A1 Inhibitors and methods of use thereof
08/04/2004EP1442023A1 Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist
08/04/2004EP1296945B1 Sulfonamide derivatives
08/04/2004CN1518534A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
08/03/2004US6770762 Process for preparing and purifying 1,7′-dimethyl-2′-propyl-2,5′-bi-1H-benzimidazole
08/03/2004US6770666 Fused-ring compounds and use thereof as drugs
08/03/2004US6770648 Antidiabetic agents
08/03/2004US6770639 Cell proliferative; autoimmune diseases; antiallergens; antiinflammatory agents; anticancer agents
07/2004
07/29/2004WO2004063190A1 Fused heterocyclic derivates as ppar modulators
07/29/2004WO2004063181A1 Urea derivatives and their use as anti-inflammatory agents
07/29/2004WO2004063170A1 A process for the synthesis of bisbenzimidazoles and its derivations
07/29/2004WO2004063169A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors
07/29/2004WO2004063155A1 Fused heterocyclic derivatives as ppar modulators
07/29/2004WO2004062663A1 Use of substituted 2-phenylbenzimidazoles as medicaments
07/29/2004WO2004062661A1 2-‘5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl!- carboxylic acid derivatives as factor viia inhibitors
07/29/2004WO2004062601A2 Antibacterial agents
07/29/2004WO2004050039A3 Spirocyclic ureas, compositions containing such compounds and methods of use
07/29/2004WO2003094861A3 Bis-benzimidazoles and related compounds as potassium channel modulators
07/29/2004US20040147758 Compounds for treatment of AIDS with enzyme inhibitors
07/29/2004US20040147573 Metalloproteinase inhibitors
07/29/2004US20040146438 Method for recovery of metals from metal-containing materials using medium temperature pressure leaching
07/29/2004CA2851462A1 Antibacterial agents
07/29/2004CA2513436A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors
07/29/2004CA2512813A1 Use of substituted 2-phenylbenzimidazoles as phamaceutical compositions
07/29/2004CA2512582A1 Antibacterial agents
07/29/2004CA2510516A1 Fused heterocyclic derivatives as ppar modulators
07/29/2004CA2509202A1 Fused heterocyclic derivatives as ppar modulators
07/28/2004EP1176958B1 Novel catechols as antimicrobial agents
07/28/2004CN1516693A Benzimidazoles that are useful in treating sexual dysfunction
07/28/2004CN1515673A Preparation method of antipode of (1R, 4S)-or (1S, 4R)-1-amino-4-(methylol)-2-cyclopentene derivative
07/28/2004CN1159289C C-terminal modified oxamyl dipetides as inhibitors of the ICE/ced-3 family of cystenine proteases
07/28/2004CN1159007C Benzimidazole compounds
07/27/2004US6768019 Enzyme inhibitors, 1-(4-methanesulfonyl-benzylidene)-3,4-dihydro-1h-naphthalene-2 -one oxime
07/27/2004US6768009 N-halamine vinyl compounds and their polymeric biocides
07/27/2004CA2103072C Pleuromutilin derivatives
07/22/2004WO2004060308A2 Thiosemicarbazones as anti-virals and immunopotentiators
07/22/2004US20040143018 Thrombosis; emphysema; antihistamines; cirrhosis; antiarthritic agents; anticancer agenst
07/22/2004US20040142850 Benzimidazolidinone derivatives
07/22/2004US20040142206 substituted with aromatic groups, e.g., 2,2'-dihexyloxy-6,6'dianthracenyl- (or 6,6'-dipyrenyl-) 1,1'-binaphthylene; good solubility in common organic solvents, resist crystallization and can be sublimed in a device fabrication process.
07/22/2004DE10300398A1 Verwendung von substituierten 2-Phenylbenzimidazolen als Arzneimittel Use of substituted 2-Phenylbenzimidazolen as drugs
07/22/2004CA2511646A1 Thiosemicarbazones as anti-virals and immunopotentiators
07/21/2004EP1439169A1 DIFLUOROALKENE DERIVATIVE, PEST CONTROL AGENT CONTAINING THE SAME, AND INTERMEDIATE THEREFOR
07/21/2004EP1438297A1 Mibefradil-based compounds as calcium channel blockers useful in the treatment of hypertension and angina
07/21/2004CN1513843A Cyano substituted heterocyclic ketene semiamine contained molecular material and its preparation method
07/21/2004CN1158269C 4-aminothiazole 2 group compound as inhibitors of cyclin-dependent kinases
07/21/2004CN1158264C Metabotropic glutamate receptor antagonists for treating central nervous system disease
07/20/2004US6765003 3-Arylsulfonyl-2 (substituted methyl) propanoic acid derivatives as matrix metalloproteinase inhibitors
07/20/2004CA2254731C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids
07/15/2004WO2004052887A3 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
07/15/2004US20040138451 Epindolidione pigments
07/15/2004US20040138255 Modulate cell signal transduction; anticarcinogenic agents; antidiabetic agents; osteoporosis
07/14/2004EP1437344A1 Benzene derivatives,process for preparing the same and use thereof
07/14/2004EP1436273A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof
07/14/2004EP1435947A1 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cds1/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer
07/14/2004EP1435946A2 Linked biaryl compounds
07/14/2004EP1435894A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
07/14/2004EP1144368B1 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors
07/14/2004CN1511832A Optical active compound used as intermediate in preparing optical activity 2-imidazoline-5-thionone derivatives
07/14/2004CN1511519A Therapy for immunological disease of type 2 T auxiliary cell mediated
07/13/2004US6762199 Ability to modulate the interaction of the ligand vcam-1 with its integrin receptor alpha 4 beta 1; treatment of inflammation, atherosclerosis, autoimmune disease
07/13/2004US6762198 Such as 2-((4'-methoxy-(1,1'-biphenyl)-4-yl)-sulfonyl)-amino-3-(2-phenoxymethyl -(1,3)dioxan-2-yl)propionic acid
07/13/2004US6762152 Four to seven membered heterocycles substituted on benzene ring; reaction of a ketone with a substituted benzoic acid
07/08/2004WO2004056784A1 Novel carboxamides, the production and use thereof as medicaments
07/08/2004WO2004056727A2 Process of making chalcone derivatives
07/08/2004WO2004056362A2 8-trialkysyloxy-2-methyl-9-phenyl-7-0 xo-7,8,9,10- tetrahydroimidazo ‘1,2-h! ‘1,7! naphthyridines
07/08/2004WO2004022060A3 (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders
07/08/2004WO2004009017A3 Modulators of the glucocorticoid receptor and method
07/08/2004US20040132777 Aryl substituted benzimidazoles and their use as sodium channel blockers
07/08/2004US20040132758 hyterocyclylaminomethyl- or aminocarbonyl-substituted 9,10-ethanoanthracenes or their aza derivatives; treating obesity, diabetes, inflammatory and immune disorders
07/08/2004US20040132741 N-sulfonylindoles and N-sulfonylindazoles; treating motor disorders, anxiety disorders or cognitive disorders, such as schizophrenia, depression, Alzheimer's disease or Parkinson's disease
07/08/2004US20040131885 Organic electroluminescent device and organic electroluminescent compound thereof
07/08/2004CA2510846A1 New carboxylic acid amides,the preparation thereof and their use as pharmaceutical compositions
1 ... 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 ... 154